The Criminal Legal Aid (General) (Amendment) Regulations 2026

Added fifteen synthetic opioids to the list of Class A controlled drugs and reclassified one cannabinoid receptor agonist from Class B to Class A.


This Order amends Schedule 2 to the Misuse of Drugs Act 1971 by adding fifteen synthetic opioids to the list of Class A controlled drugs.

It subjects these substances—primarily nitazenes and their derivatives—to the highest level of statutory control under UK law, affecting manufacturers, distributors, and individuals in possession of these chemicals.

The Order also reclassifies Cumyl-Pepegaitienate from a Class B to a Class A substance and removes specific naming of Diphenoxylate from Class B to avoid duplication with its Class A status.

Arguments For

  • The Explanatory Memorandum states that the Advisory Council on the Misuse of Drugs (ACMD) recommended these classifications due to the high potency of synthetic opioids and the associated risks of severe toxicity and fatality.

  • Proponents argue that bringing these substances under the 1971 Act enables law enforcement to apply stricter penalties for the production, supply, and possession of these specific compounds.

  • The order cites the need to update the list of controlled substances to keep pace with the emergence of new psychoactive substances in the illicit drug market.

Arguments Against

  • Legal scholars and health advocates have previously noted that rapid reclassification may lead to the emergence of newer, even less-understood chemical analogues to bypass specific legal definitions.

  • Affected parties in the scientific and research communities have expressed concerns that Class A designation increases the administrative burden and costs for obtaining licenses required for legitimate laboratory research.

  • Some harm reduction organizations argue that criminalization alone may not address the underlying demand or the risks of accidental overdose without accompanying public health interventions.

  1. This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2024 and comes into force on the twenty-eighth day after the day on which it is made.
  1. In Part 1 of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the drugs which are subject to control under that Act as Class A drugs)— (a) in paragraph 1(a)— (i) after “Desomorphine”, insert— “2-(2-(4-Deoxy-4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Flunitazene);”; (ii) after “Diethylthiambutene”, insert— “2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Etunitazene);”; (iii) after “Dimenoxadole”, insert— “N,N-Diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (Isotonitazene);”; (iv) after “N,N-Diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (Metonitazene)”, insert— “N,N-Diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Protonitazene); N,N-Diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (F-Etonitazene); N,N-Diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Metodesnitazene); 2-(2-(4-Ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Etodesnitazene); 2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine (Dimetnitazene); N,N-Diethyl-2-(2-(4-methylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (Butonitazene); 2-(2-(4-Chlorobenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Clonitazene);”; (v) after “Nicomorphine (3,6-dinicotinomorphine)”, insert— “2-(4-Ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Etonitazepyne); 2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Isotonitazepyne); 5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Protonitazepyne); 1-(2-(Azepan-1-yl)ethyl)-2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazole (Etonitazepipne);”; (vi) after “Normorphine”, insert— “N-Pyrrolidino protonitazene;”; (b) in paragraph 1(b), after “Bufotenine”, insert— “1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Cumyl-Pepegaitienate);”.
  1. In Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the drugs which are subject to control under that Act as Class B drugs)— (a) in paragraph 1(a), omit “Diphenoxylate”; (b) in paragraph 1(ca), omit “1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Cumyl-Pepegaitienate)”

Related

The Regulation of Investigatory Powers (Directed Surveillance and Covert Human Intelligence Sources) (Amendment) Order 2026

Wed 2nd Sept 26

Authorized regulators to impose civil financial penalties and stop notices for environmental offenses in England.

Read More

The Air Navigation (Restriction of Flying) (Blackpool Illuminations) Regulations 2026

Wed 2nd Sept 26

Restricted the flight of unmanned aircraft below 1,100 feet in Blackpool on 4 September 2026.

Read More

The Air Navigation (Restriction of Flying) (Rali Ceredigion) Regulations 2026

Wed 2nd Sept 26

Established temporary no-fly zones and altitude limits across Ceredigion to manage airspace safety during the 2026 Rali Ceredigion motor rally.

Read More

The Sentencing Act 2026 (Commencement No. 6 and Revocation) Regulations 2026

Wed 2nd Sept 26

Activated new sentencing laws that reduce the time most prisoners must serve before release, implemented via a phased timeline between October 2026 and June 2027.

Read More